ZOLDONAT 4MG INJECTION

Zoldonat, 4mg Injection, is a source of the active ingredient Zoledronic Acid. It is a member of the group of compounds known as bisphosphonates. It’s used to decrease the amount of calcium in the blood of patients whose levels are too high due to tumors. Tumors may accelerate regular bone changes to the point in which the release rate out of bone increases. This is referred to as hypercalcemia caused by tumors (TIH). It can also help avoid bone-related complications for adult patients suffering from bone metastases and multiple myeloma caused by cancerous solid tumors (spread in cancer that extends from the original site onto the bone), as well as a conventional cancer treatment.
Zoldonat 4mg Injection is recommended to treat or prevent osteoporosis (a condition in which bones weaken and thin and can break easily) for women who have gone through menopausal changes. It can also be employed to combat osteoporosis in males. It’s also utilized to treat Paget’s Disease of bones (a condition where bones are brittle and weak and are susceptible to deformation, pain, or fracture). Other applications include preventing or treating osteoporosis for women and men taking glucocorticoids (a corticosteroid medicine that can result in osteoporosis).
Don’t take this medication if you are sensitive to zoledronic acid, any other bisphosphonate, or any other ingredient in this medication or when you are pregnant or nursing. Before starting treatment, notify your doctor of any liver or kidney problems, bone conditions, swelling, pain, or numb jaw. This medication is not recommended for use by adolescents or youngsters under the age of 18 years old. Zoldonat, 4 mg Injection, is not chemotherapy for cancer and is not able to slow or slow the spread of cancer. It can, however, be utilized to treat bone disease in cancer patients.